StonvexLoading…
StonvexStonvexStonvexCore line items from MYSE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $550.00 | $436.00 | $672.00 | $46.21K |
Operating Income | $-5.49M | $-3.22M | $-8.78M | $-12.23M |
Net Income | $-2.61M | $-4.24M | $-8.40M | $-12.14M |
EPS (Diluted) | $-0.62 | $-1.43 | $-4.14 | $-6.04 |
Total Assets | $7.20M | $5.37M | $6.51M | $13.11M |
Total Liabilities | $1.09M | $630.31K | $406.55K | $557.11K |
Cash & Equivalents | $749.03K | $766.99K | $953.36K | $1.73M |
Free Cash Flow OCF − CapEx | $-4.27M | Not available | $-6.58M | $-7.30M |
Shares Outstanding | 4.26M | 3.01M | 2.04M | 2.06M |